Your browser doesn't support javascript.
loading
The incidence rate of hospitalized lysosomal storage diseases in Poland in 2013-2015 based on data from the National Health Fund.
Grzeszczak, Wladyslaw; Franek, Edward; Szypowska, Agnieszka; Filipow, Winicjusz; Zieba, Mariusz; Kabicz, Pawel; Wieckowska, Barbara.
Afiliação
  • Grzeszczak W; Chair and Department of Internal Medicine, Diabetology, and Nephrology, Silesian University of Medicine, Zabrze, Poland.
  • Franek E; The Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
  • Szypowska A; Department of Internal Diseases, Endocrinology and Nephrology, Central Clinical Hospital of the Ministry of Interior Affairs and Administration, Warsaw, Poland.
  • Filipow W; Department of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
  • Zieba M; Department of Research and Development and Innovative Medicine for Metabolic Diseases at the Diabetic Clinic, Nysa, Poland.
  • Kabicz P; Department of Analyses and Strategy, Ministry of Health, Warsaw, Poland.
  • Wieckowska B; Department of Analyses and Strategy, Ministry of Health, Warsaw, Poland.
Pediatr Endocrinol Diabetes Metab ; 27(3): 191-198, 2021.
Article em En | MEDLINE | ID: mdl-34498441
ABSTRACT

INTRODUCTION:

The reported data address the incidence of lysosomal storage diseases, obtained from the public health service databases in Poland. Data are given by subtypes from the National Health Fund between 2013 and 2015. MATERIAL AND

METHODS:

Patients with lysosomal storage diseases were identified in the National Health Fund database (2013-2015). In order to ensure that the reported incidence data included only new patients. The geographic area of residence in 2013-2015 was divided into 6 parts.

RESULTS:

The incidence rate of lysosomal storage diseases in Poland is about 1.84/1 million/person/years. Other sphingolipidosis was the largest disease category, with 127 patients (incidence 1.1 patients/million habitants), follow by GM2 gangliosidosis - 29 patients (incidence 0.25 patients/million habitants). Men had a somewhat higher incidence than women (respectively IR = 2.53, IR = 1.84). The number of deaths with lysosomal storage disease patients hospitalized between the years 2013 through 2015 is higher in young people (0-9 years old).

CONCLUSIONS:

The incidence rate of lysosomal storage diseases in Poland is about 1.84 per million person-years. Other sphingolipidosis was the largest disease category, followed by GM2 gangliosidosis. The hospitalization rate of lysosomal storage diseases was higher in men.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças por Armazenamento dos Lisossomos / Administração Financeira Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Região como assunto: Europa Idioma: En Revista: Pediatr Endocrinol Diabetes Metab Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças por Armazenamento dos Lisossomos / Administração Financeira Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Região como assunto: Europa Idioma: En Revista: Pediatr Endocrinol Diabetes Metab Ano de publicação: 2021 Tipo de documento: Article